Study ID: TV48125-PK-10078
Study Title
- To Assess Pharmacokinetics, Safety and Tolerability of TEV-48125 in Japanese and Caucasian Healthy Subjects After a Single Subcutaneous (SC) Administration of TEV-48125
Teva Identifier
- TV48125-PK-10078
ClinicalTrials.gov Identifier
- NCT02673567
Study Status
- Completed
Trial Condition(s)
- Pharmacokinetics
Interventions
- Drug: TEV-48125 - 1 | Drug: TEV-48125 - 2 | Drug: TEV-48125 - 3 | Drug: Placebo
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years to 55 Years
Trial Duration
- March 31, 2016 - February 10, 2017
Phase
- Phase 1
Study Type
Interventional
